Agents for intravitreal administration to treat or prevent disorders of the eye

   
   

Methods and preparations for treating disorders of the eye and/or causing posterior vitreous disconnection or disinsertion. Preparations containing a) urea, b) urea derivatives (e.g., hydroxyurea, thiourea), c) a non-steroidal anti-inflamatory agents, d) antmetabolites, e) urea, urea derivatives, non-enzymatic proteins, nucleosides, nucleotides and their derivatives (e.g., adenine, adenosine, cytosine, cytadine, guanine, guanitadine, guanidinium, thymidine, thimitadine, uradine, uracil, cystine), uric acid, calcium acetal salicylate, ammonium sulfate or other compound capable of causing non-enzymatic dissolution of the hyaloid membrane or e) any of the possible combinations thereof, are administered to the eye in therapeutically effective amounts.

 
Web www.patentalert.com

< Allomone repulsive and kairomone attractive compositions for controlling arachnids

< Use of agents that down-regulate expression of tanis and/or p21^Waf1/Cip1/Sd1 genes, and use of agents that inhibit, degrade, sequester or prevent the neurotoxicity of gene product proteins of tanis and p21^Waf1/Cip1/Sd1 genes

> Novel compounds

> UspA1 and UspA2 antigens of Moraxella catarrhalis

~ 00189